Cartilage Repair/Regeneration Market by Treatment Modality (Cell Based and Non-Cell Based), by Treatment (Cartilage Replacement and Cartilage Repair), by Type (Fibro Cartilage, Hyaline Cartilage, and Elastic Cartilage), and by End-Use (Ambulatory Surgical Centers, Hospitals & Clinics, Surgical Centers, and Others)-Global Industry Analytics, Comprehensive Analysis & Forecast, 2020 - 2029

                                          
Abstract
                    
The report covers forecast and analysis for the cartilage repair/regeneration market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the cartilage repair/regeneration market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cartilage repair/regeneration market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the cartilage repair/regeneration market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein by treatment modality, type, treatment, end use, and by region the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, regional expansion of major participants involved in the market on the global and regional basis. 

The study provides a decisive view of the cartilage repair/regeneration market by segmenting the market based on by treatment modality, by type, by treatment, by end use, and by region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024.

Based on treatment modality, cartilage repair/regeneration market has been segmented into cell-based and non-cell based. The cell-based segment is sub-segmented into growth factor technology, chondrocyte transplantation, and stem cells and the non-cell based segment is sub-segmented into cell-free composites, tissue scaffolds, and stem cells. By treatment modality, cell-based treatment is estimated to hold the largest market value share attributed to the fact of long-term & effective results.

On the basis of treatment, cartilage repair/regeneration market has been segmented into cartilage replacement and cartilage repair. The cartilage replacement segment is sub-segmented into autologous chondrocyte implantation and osteochondral transplant and the cartilage repair segment is sub-segmented into cell-based cartilage resurfacing, microfracture, and non-surgical treatment.

By type segment, cartilage repair/regeneration market is bifurcated into fibrocartilage, hyaline cartilage, and elastic cartilage. 
Based on end use, cartilage repair/regeneration market is classified ambulatory surgical centers, surgical centers, hospitals and clinics, and others. Hospital & clinics segment held the maximum share and is expected to boost the market over the forecast period.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further divided into major countries which include the U.S. Canada, Germany, France, UK, China, Japan, India, and Brazil.

The report also includes detailed profiles of end players such as include Osiris Therapeutics, Inc., Smith & Nephew Plc, Vericel Corporation, Depuy Synthes, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Anika Therapeutics S. R. L, Conmed Linvatec, RTI Surgical, Arthrex, Inc., and others. 

This report segments the global cartilage repair/regeneration market as follows:

Global Cartilage Repair/Regeneration Market: By Treatment Modality

	Cell-Based
	
		Growth Factor Technology
		
			TGFs
			BMPs
			PDGF
			IGF-1
		
		
		Chondrocyte Transplantation
		Stem Cells
	
	
	Non-Cell Based
	
		Cell-Free Composites
		Tissue Scaffolds
		Stem Cells
	
	

Global Cartilage Repair/Regeneration Market: By Type

	Fibro Cartilage
	Hyaline Cartilage    
	Elastic Cartilage

Global Cartilage Repair/Regeneration Market: By Treatment

	Cartilage Replacement
	
		Autologous Chondrocyte Implantation
		Osteochondral Transplant
	
	
	Cartilage Repair
	
		Cell-based Cartilage Resurfacing
		Microfracture
		Non-Surgical Treatment
		
			Steroid Injections
			Physical Therapy
		
		
	
	

Global Cartilage Repair/Regeneration Market: By End-Use

	Ambulatory Surgical Centers
	Hospitals & Clinics
	Surgical Centers
	Others 

Global Cartilage Repair/Regeneration Market: By Region

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	The Middle East and Africa